Broad-spectrum Antibiotics (e.g., Ciprofloxacin + Metronidazole)
Treatment for Vascular Intestinal Disorders
Typical Dosage: Ciprofloxacin 400mg IV q12h + Metronidazole 500mg IV q8h
Effectiveness
70%
Safety Score
70%
Clinical Trials
50
Participants
5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Ciprofloxacin 400mg IV q12h + Metronidazole 500mg IV q8h
Time to Effect
24-48 hours
Treatment Duration
7-14 days
Evidence Quality
MODERATENumber Needed to Harm (NNH)
50(Treat 50 patients to see 1 additional serious adverse event)
Confidence Score
70%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$500
Side Effect Mgmt:$300
Total Annual:$1,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$1,538
Comparison vs Supportive Care Only
Cost Difference
$-20,000/year
Less expensive
QALY Difference
+0.80 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Broad-spectrum Antibiotics (e.g., Ciprofloxacin + Metronidazole) Outcomes
for Vascular Intestinal Disorders
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+65%
Common Side Effects
Diarrhea (incl. C. difficile)
+10%
Nausea/Vomiting
+5%
Allergic reactions
+2%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov